New cancer clinical trial: Icotinib as Consolidation Therapy After Chemoradiotherapy in EGFR-Mutant Stage IIIA-IIIB Non-small Cell Lung Cancer

Published on: January 10, 2018 at 12:00PM
Conditions:   EGFR Gene Mutation;   Non Small Cell Lung Cancer Stage IIIA;   Non Small Cell Lung Cancer Stage IIIB
Intervention:   Drug: Icotinib
Sponsor:   Betta Pharmaceuticals Co.,Ltd.
Recruiting
http://ift.tt/2qTgJvC